Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 16Lymphoma 16Leukemia, Myeloid, Acute 16Lymphoma, Non-Hodgkin 15Lymphoma, Mantle-Cell 15Lymphoma, Large-Cell, Immunoblastic 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Follicular 14Leukemia 13Neuroblastoma 12Multiple Myeloma 12Lymphoma, B-Cell, Marginal Zone 12Hodgkin Disease 12Myelodysplastic Syndromes 11Leukemia, Myelomonocytic, Chronic 10Breast Neoplasms 10Myeloproliferative Disorders 9Congenital Abnormalities 9Sezary Syndrome 7Ovarian Neoplasms 7Neoplasms, Plasma Cell 7Mycosis Fungoides 7Lymphoma, T-Cell, Cutaneous 7Anemia, Refractory, with Excess of Blasts 7Sarcoma 6Myelodysplastic-Myeloproliferative Diseases 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Accelerated Phase 6

Interventions

Vincristine 2Topotecan 2Stem Cell Transplantation 2Radiation 2Platinum 2Melphalan 2Doxorubicin 2Cyclophosphamide 2Congresses as Topic 2Cisplatin 2Busulfan 21,2-diaminocyclohexaneplatinum II citrate 2etoposide phosphate 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Isotretinoin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Ganglioneuroblastoma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT01798004 2024-07-15

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Children's Oncology Group

Phase 1 Completed
150 enrolled 9 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡